Heart disease is a leading cause of death worldwide, with men particularly susceptible to its often life-threatening ...

A loved one waking you with loud snoring, followed by gasping and choking sounds, might signal more than minor sleep ...

Dignity Health January marks Healthy Weight Awareness Month, and with the new year, many are setting health and weight loss ...

Sleep apnea affects millions globally, often lurking undetected until it begins impacting overall health. While high blood ...

Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational ...

There are many consequences of untreated OSA, and all of these are more likely with more-severe obstruction. Because people with OSA don't sleep well, they are at a higher risk for motor vehicle ...

The FDA has approved Zepbound (tirzepatide) for the treatment of moderate to severe obstructive sleep apnea in adults with ...

The U.S. FDA has approved Zepbound (tirzepatide) as the first prescription medication for the treatment of obstructive sleep apnea.

Between 30-50% of adults with hypertension have OSA, and this number increases to between 70-80% in adults with resistant hypertension. Additionally, untreated moderate-to-severe OSA increases the ...

People whose jobs are highly sedentary – an estimated 80% of the modern workforce – experience a much higher risk of insomnia symptoms, according to a new study led by University of South Florida ...

Obstructive sleep apnea (OSA) is a common sleep disorder characterized by intermittent airway blockages during sleep, leading ...